Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial. (Q50623510)

16 March 2018

title

Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial. (English)

1 reference

16 March 2018

9

Roland Hetzer

1 reference

16 March 2018

Christoph Knosalla

7

Christoph Knosalla

1 reference

16 March 2018

Michael Dandel

3

Michael Dandel

1 reference

16 March 2018

Boris A Nasseri

1

Boris A Nasseri

1 reference

16 March 2018

Yeong-Hoon Choi

8

Yeong-Hoon Choi

1 reference

16 March 2018

Wolfram Ebell

2

Wolfram Ebell

1 reference

16 March 2018

Christof Stamm

10

Christof Stamm

1 reference

16 March 2018

Marian Kukucka

4

Marian Kukucka

1 reference

16 March 2018

author name string

Rolf Gebker

5

1 reference

16 March 2018

Adelina Doltra

6

1 reference

16 March 2018

publication date

3 February 2014

1 reference

16 March 2018

published in

European Heart Journal

1 reference

16 March 2018

volume

35

1 reference

16 March 2018

page(s)

1263-1274

1 reference

16 March 2018

issue

19

1 reference

16 March 2018

Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

Cell therapy for heart disease: great expectations, as yet unmet

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

Two-dimensional speckle tracking strain analysis for efficacy assessment of myocardial cell therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

Measurement of health-related quality of life in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

Direct isolation of human central nervous system stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

Transmyocardial laser revascularization combined with intramyocardial endothelial progenitor cell transplantation in patients with intractable ischemic heart disease ineligible for conventional revascularization: preliminary results in a highly sele

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

Mid term results after bone marrow laser revascularization for treating refractory angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

Cardiac cell therapy: a realistic concept for elderly patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU007

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHU007

1 reference

16 March 2018

PubMed ID

24497345

1 reference

16 March 2018